Back to HUNTINGTON NATIONAL BANK HUNTINGTON NATIONAL BANK

SRNESRNE
Showing 8 of 25 quarters

Position history for HUNTINGTON NATIONAL BANKHUNTINGTON NATIONAL BANK's holdings in Sorrento Therapeutics Inc

HUNTINGTON NATIONAL BANK holds 5,001 shares of SRNE (Sorrento Therapeutics Inc), worth $4 as of 2026-Q2.

Current Value

$4

Current Shares

5,001

Total Value Change

-$16

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
5,001
0.0%
$40.0%$0.01
0
2026-Q1
Unchanged
5,001
0.0%
$160.0%$0.01
0
2025-Q4
Unchanged
5,001
0.0%
$140.0%$0.01
0
2025-Q3
Unchanged
5,001
0.0%
$190.0%$0.01
0
2025-Q2
Unchanged
5,001
0.0%
$60.0%$0.01
0
2025-Q1
Unchanged
5,001
0.0%
$40.0%$0.01
0
2024-Q4
Unchanged
5,001
0.0%
$40.0%$0.01
0
2024-Q3
Unchanged
5,001
0.0%
$200.0%$0.01
0

Other major holders of SRNE: BNP PARIBAS FINANCIAL MARKETS, Steward Partners Investment Advisory, LLC, GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used